Skip to main content
. 2022 Oct 12;2022:2948248. doi: 10.1155/2022/2948248

Table 1.

General data of DKD patients.

Parameters
Number 85
Age (years) 48.6 ± 12.6
Sex, male/female 64/21
Diabetes history (months) 120 (60, 168)
Proteinuria (g/24 h) 4.0 (2.3, 7.6)
uACR (mg/g) 3223.6 (1691.3, 5837.5)
Scr (μmol/L) 174.3 (105.0, 309.9)
BUN (mmol/L) 11.2 (7.7, 15.4)
eGFR (mL/min/1.73 m2) 37.2 (20.3, 61.9)
eGFR slope (mL/min/1.73 m2/year) -5.8 (-6.0, -4.8)
FBG, mmol/L 6.5 (5.5,8.5)
HbA1c (%) 6.8 (5.8, 8.0)
Hb (g/L) 111.0 ± 23.2
Serum albumin (g/L) 32.8 ± 6.0
TG (mmol/L) 1.7 (1.2, 2.6)
HDL-C (mmol/L) 1.0 (0.8, 1.2)
LDL-C (mmol/L) 2.8 (2.0, 3.7)
Pathological type, I/II/III/IV 5/14/60/6
IFTA score, grade 0/1/2/3 0/20/24/41
Inflammation score, grade 0/1/2 0/33/52
Arteriole hyalinosis score, grade 0/1/2 22/63/0
Atherosclerosis score, grade 0/1/2 3/49/33
RAAS inhibitors (%) 70.6 (60/85)
Lipid-lowering drugs (%) 57.6 (49/85)

BUN: blood urea nitrogen; DKD: diabetic kidney disease; eGFR: estimated glomerular filtration rate; FBG: fasting blood glucose; Hb: hemoglobin; HbA1c: hemoglobin A1c; HDL-C: high-density lipoprotein-cholesterol; IFTA: interstitial fibrosis and tubular atrophy; LDL-C: low-density lipoprotein-cholesterol; RAAS: renin-angiotensin-aldosterone system; Scr: serum creatinine; TG: triglyceride; uACR: urinary albumin-to-creatinine ratio. The continuous data were expressed as mean ± SD or median and IQR as appropriate.